机译:Autotaxin抑制剂的更新专利综述(2017年至今)
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design & Discovery Minist Educ Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design & Discovery Minist Educ Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design & Discovery Minist Educ Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design & Discovery Minist Educ Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design & Discovery Minist Educ Shenyang 110016 Peoples R China;
ATX inhibitor; binding modes; ATX-LPA axis; fibrosis; cancer;
机译:组蛋白脱乙酰酶(HDAC)癌症抑制剂:专利综述(2017年至今)
机译:Autotaxin抑制剂:一项专利审查(2012-2016年)
机译:Autotaxin抑制剂:一项专利审查
机译:专利状态审查和超高压专利分析
机译:设计,合成和生物学评估膦酸酯类似物作为自分泌运动抑制剂(ATX,NPP2)的抑制剂。
机译:勘误症:早产儿血小板计数和专利导管血管术:更新的系统审查和荟萃分析
机译:勘误症:早产儿血小板计数和专利导管血管术:更新的系统审查和荟萃分析